Pyxis Oncology, Inc.PYXSNASDAQ
LOADING
|||
Switch Symbol:
EBITDA Over Time
Trending higher, strong compound growth.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-65.51M
↓ 11% below average
Average (5y)
$-58.80M
Historical baseline
Range
High:$-2.77M
Low:$-122.77M
CAGR
+88.2%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-65.51M | +18.4% |
| 2023 | $-80.27M | +34.6% |
| 2022 | $-122.77M | -77.8% |
| 2021 | $-69.07M | -457.7% |
| 2020 | $-12.38M | -346.8% |
| 2019 | $-2.77M | - |